BRENTUXIMAB VEDOTIN

Clinical trials for BRENTUXIMAB VEDOTIN explained in plain language.

Never miss a new study

Get alerted when new BRENTUXIMAB VEDOTIN trials appear

Sign up with your email to follow new studies for BRENTUXIMAB VEDOTIN, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 2

New hope for young hodgkin lymphoma patients: trial aims to boost cure rates, cut radiation

Disease control Recruiting now

This study is testing a new combination of cancer drugs for children, teens, and young adults (ages 2-35) newly diagnosed with classical Hodgkin lymphoma. The main goal is to improve the rate of early, complete response to treatment, which could allow more patients to avoid radia…

Matched conditions: BRENTUXIMAB VEDOTIN

Phase: PHASE2, PHASE3 • Sponsor: Children's Cancer Group, China • Aim: Disease control

Last updated Mar 30, 2026 14:28 UTC

BRENTUXIMAB VEDOTIN

Get alerted when new BRENTUXIMAB VEDOTIN trials appear

New hope for young hodgkin lymphoma patients: trial aims to boost cure rates, cut radiation